NCT07566923

Brief Summary

This study will evaluate the effects of non-invasive vagus nerve stimulation in adolescents aged 12 to 18 years who have burn injuries. The study will include patients who have completed the acute phase after burn injury and who have symptoms such as anxiety, sleep problems, pain, or itching. Participants will be randomly assigned to one of two groups. One group will receive conventional physiotherapy together with non-invasive vagus nerve stimulation. The other group will receive only conventional physiotherapy. The treatment program will be applied 5 days per week for a total of 10 sessions. The study will assess whether non-invasive vagus nerve stimulation improves anxiety, sleep quality, pain, itching, and autonomic nervous system function. These outcomes will be measured before and after the treatment program using clinical scales and heart rate variability measurements.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
4mo left

Started May 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress5%
May 2026Sep 2026

First Submitted

Initial submission to the registry

April 28, 2026

Completed
3 days until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 5, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

May 5, 2026

Status Verified

April 1, 2026

Enrollment Period

4 months

First QC Date

April 28, 2026

Last Update Submit

April 28, 2026

Conditions

Keywords

Non-invasive vagus nerve stimulationBurn injuryAdolescent burn patientsAnxietySleep qualityPainPruritus

Outcome Measures

Primary Outcomes (5)

  • Change in anxiety level

    Anxiety level will be assessed using the Beck Anxiety Inventory. The scale consists of 21 items scored from 0 to 3, with a total score ranging from 0 to 63. Higher scores indicate higher anxiety severity.

    Baseline and after completion of the 10-session treatment program, approximately 2 weeks

  • Change in sleep-related symptoms

    Sleep-related symptoms will be assessed using the Adolescent Insomnia Scale. The scale includes 13 items and evaluates sleep onset, sleep maintenance, and sleep dissatisfaction/disturbances. Total scores range from 0 to 52, with higher scores indicating more severe insomnia symptoms.

    Baseline and after completion of the 10-session treatment program, approximately 2 weeks

  • Change in pain intensity

    Pain intensity will be assessed using the Visual Analog Scale. Participants will mark their pain level on a 100-mm line, where higher scores indicate greater pain intensity.

    Baseline and after completion of the 10-session treatment program, approximately 2 weeks

  • Change in pruritus severity

    Pruritus severity will be assessed using the 12-Item Pruritus Severity Scale. The scale evaluates the severity, frequency, duration, distribution, and impact of itching on daily life and sleep. Higher scores indicate more severe pruritus.

    Baseline and after completion of the 10-session treatment program, approximately 2 weeks

  • Change in heart rate variability parameters

    Autonomic nervous system function will be assessed using heart rate variability measurements recorded with a Polar H10 heart rate sensor. RR interval data will be analyzed using Kubios HRV software. Time-domain, frequency-domain, and non-linear heart rate variability parameters will be evaluated.

    Baseline and after completion of the 10-session treatment program, approximately 2 weeks

Study Arms (2)

Non-Invasive Vagus Nerve Stimulation Plus Conventional Physiotherapy

EXPERIMENTAL

Participants in this group will receive non-invasive vagus nerve stimulation in addition to conventional physiotherapy. The treatment will be applied 5 days per week for a total of 10 sessions.

Device: Non-Invasive Vagus Nerve StimulationOther: Conventional Physiotherapy

Conventional Physiotherapy

ACTIVE COMPARATOR

Participants in this group will receive conventional physiotherapy only. The treatment will be applied 5 days per week for a total of 10 sessions.

Other: Conventional Physiotherapy

Interventions

Non-invasive vagus nerve stimulation will be applied using electrodes placed on the tragus and concha regions of both ears. Stimulation will be delivered with a biphasic asymmetrical waveform, a pulse duration of 300 microseconds, and a frequency of 25 Hz for 20 minutes. The stimulation intensity will be gradually increased in 0.1 mA steps until the participant's sensory threshold is reached. The intervention will be applied 5 days per week for a total of 10 sessions.

Non-Invasive Vagus Nerve Stimulation Plus Conventional Physiotherapy

Participants will receive an individualized conventional physiotherapy program based on their clinical needs. The program may include strengthening exercises, stretching exercises, balance exercises, active and passive range-of-motion exercises, and interventions for edema management. Each session will last approximately 45 minutes and will be applied 5 days per week for a total of 10 sessions.

Conventional PhysiotherapyNon-Invasive Vagus Nerve Stimulation Plus Conventional Physiotherapy

Eligibility Criteria

Age12 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Being between 12 and 18 years of age
  • Having completed the acute phase after burn injury, with at least 1 month and at most 1 year since the burn injury
  • Having second- or third-degree burns involving 5% to 30% of total body surface area
  • Having at least one of the following complaints: anxiety, poor sleep quality, pain, or itching
  • Written informed consent provided by the parent or legal guardian, and willingness of the participant to take part in the study
  • Ability to read and understand Turkish

You may not qualify if:

  • Infection, ulcer, or scar tissue on the auricle
  • Burn injury in the head and neck region that prevents application of the device to the auricular vagus nerve area
  • Metallic implant in the skull, excessive sensitivity in the ear, ear injury, or ear inflammation
  • Chronic pulmonary and/or cardiac disease
  • Heart rate below 60 beats per minute
  • Presence of a pacemaker, cochlear implant, or similar implanted device
  • Uncontrolled hypertension
  • Lack of cooperation
  • Refusal or inability of the parent or legal guardian to sign the informed consent form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kartal Dr. Lütfi Kırdar City Hospital Burn Unit

Istanbul, Kartal, 34865, Turkey (Türkiye)

Location

MeSH Terms

Conditions

BurnsAnxiety DisordersSleep Initiation and Maintenance DisordersPainPruritus

Condition Hierarchy (Ancestors)

Wounds and InjuriesMental DisordersSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSkin DiseasesSkin and Connective Tissue DiseasesSkin Manifestations

Study Officials

  • Sümeyye Akçay, Asst. Prof.

    Fenerbahçe University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcomes assessor will be blinded to group allocation. Participants will be evaluated before and after the intervention by an assessor who will not be involved in treatment allocation or intervention delivery.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to one of two parallel groups. The intervention group will receive non-invasive vagus nerve stimulation in addition to conventional physiotherapy, while the control group will receive conventional physiotherapy only. Outcomes will be assessed before and after the 10-session treatment program.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asst. Prof.

Study Record Dates

First Submitted

April 28, 2026

First Posted

May 5, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

May 5, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to the involvement of pediatric participants and the sensitive nature of clinical and health-related data. Study results may be reported in aggregate form in scientific presentations or publications, without identifying individual participants.

Locations